GENOME ANNOUNCEMENT {#s0}
===================

Resistance against carbapenems, which are considered last-resort antibiotics, has been on the rise in the past decade ([@B1]), and resistance against colistin, an antibiotic used to treat carbapenem-resistant cases, has also been reported ([@B2]). While the mechanisms are diverse, the most common modes of resistance involve the production of antibiotic-degrading enzymes, modifications in the bacterial cell membrane, or through mutations ([@B3]).

Eleven clinical isolates of *Klebsiella pneumoniae* were collected during a passive surveillance of antimicrobial resistance in two branches of a teaching hospital in metropolitan Manila, Philippines ([@B4]). Nine of these isolates (ARPG-315, ARPG-340, ARPG-372, ARPG-379, ARPG-380, ARPG-381, ARPG-489, ARP-657, and ARP-664) were resistant to the carbapenems ertapenem, imipenem, and meropenem, of which two (ARP-657 and ARP-664) were also resistant to colistin. The two other isolates (ARPG-281 and ARPG-318) were susceptible to all three carbapenems, as well as colistin, but resistant to other antibiotics, including second-, third-, and fourth-generation cephalosporins. These two were isolated from the same patients from whom carbapenem-resistant *K. pneumoniae* strains were subsequently isolated. To further investigate the genetic basis of resistance in these isolates, whole-genome sequencing was performed.

Total DNA and plasmid DNA were extracted using the Wizard SV genomic DNA purification system (Promega Corporation) and PhasePrep BAC DNA kit (Sigma-Aldrich), respectively, according to the manufacturer's protocol. Libraries were prepared separately for genomic and plasmid DNA using the Nextera library preparation kit (Illumina). Sequencing was carried out on an Illumina MiSeq platform and was performed twice for some samples to increase coverage. DNA and plasmid sequences were combined during analyses. FastQC version 0.11.2 (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc>), and TrimGalore! version 0.3.8 (<http://www.bioinformatics.babraham.ac.uk/projects/trim_galore>) were used to preprocess the reads, while SPAdes version 3.5.0 ([@B5], [@B6]) was used for *de novo* assembly. CONTIGuator version 2.7 ([@B7]) was utilized to order the assemblies along the reference strain *K. pneumoniae* KPNIH31 sequence (accession no. [NZ_CP009876](https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP009876)) ([@B8]). Only contigs with ≥1 kbp length were used for subsequent analysis. For annotation, the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (<http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html>) ([@B9]) was used.

Details on the assembly statistics are presented in [Table 1](#tab1){ref-type="table"}. Sequencing coverage ranged from 47.78 to 131.35×, while assembly sizes were from 5.37 Mbp to 5.70 Mbp. The number of coding sequences (CDSs), rRNAs, and tRNAs annotated were, on average, 5,501, 15, and 77, respectively. *In silico* multilocus sequence typing (MLST) through the Pasteur MLST server (<http://bigsdb.web.pasteur.fr>) classified the isolates into five clonal groups (sequence type 1 \[ST-1\], ST-147, ST-273, ST-392, and ST-656), while plasmid typing using PlasmidFinder version 1.2 (<https://cge.cbs.dtu.dk/services/PlasmidFinder>) revealed multiple plasmid sequences. Furthermore, ResFinder version 2.1 (<https://cge.cbs.dtu.dk/services/ResFinder>) was able to predict resistance genes against different classes of antibiotics, including known carbapenemase genes *bla*~NDM-1~ in two carbapenem-resistant isolates (ARP-657 and ARP-664) and *bla*~NDM-7~ in five carbapenem-resistant isolates (ARPG-340, ARPG-372, ARPG-379, ARPG-380, and ARPG-381). No carbapenemase genes were annotated in the assemblies of the carbapenem-resistant isolates ARPG-315 and ARPG-489. Meanwhile, no colistin resistance genes were found in the colistin-resistant isolates ARP-657 and ARP-664.

###### 

Assembly statistics and annotations of the 11 multiple-drug-resistant *Klebsiella pneumoniae* clinical isolates

  Isolate    Genome coverage (×)   Assembly size (bp)   No. of contigs   No. of CDSs, no. of rRNAs, no. of tRNAs   No. of MLSTs   Plasmid types                          Resistance genes                                                                                                                                                                                                          Accession no.
  ---------- --------------------- -------------------- ---------------- ----------------------------------------- -------------- -------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------
  ARPG-281   52.19                 5,399,126            88               5,363, 9, 77                              1              IncFIB(K), IncR, IncFII(K)             *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aph(3ʹ)-Ia*, *ARR-3*, *bla*~DHA-1~, *bla*~OXA-1~, *bla*~SHV-1~, *catB3*, *fosA*, *oqxA*, *oqxB*, *qnrB4*, *sul1*                                                                           [NBOH00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOH00000000)
  ARPG-315   107.55                5,372,623            43               5,282, 9, 77                              1              IncFIB(K), IncR, IncFII(K)             *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *ARR-3*, *bla*~DHA-1~, *bla*~OXA-1~, *bla*~SHV-1~, *catB3*, *dfrA1*, *fosA*, *oqxA*, *oqxB*, *qnrB4*, *sul1*, *tet*(A)                                                                      [NBOI00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOI00000000)
  ARPG-318   67.8                  5,395,829            53               5,286, 19, 77                             147            IncR, IncFIA(HI1)                      *aac(3)-IIa*, *aac(6ʹ)Ib-cr*, *bla*~CTX-M-15~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA14*, *fosA*, *oqxA*, *oqxB*, *qnrB66*, *strA*, *strB*, *sul2*, *tet*(A)                                          [NBOJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOJ00000000)
  ARPG-340   131.35                5,662,273            89               5,685, 20, 76                             273            IncHI1B, IncA/C2, IncFIB(Mar), IncX3   *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aadA5*, *aph(3′)-Ic*, *bla*~CTX-M-15~, *bla*~NDM-7~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA17*, *erm*(42), *floR*, *fosA*, *mph*(A), *oqxA*, *oqxB*, *qnrS1*, *sul1*   [NBOK00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOK00000000)
  ARPG-372   68.02                 5,704,983            181              5,754, 16, 77                             273            IncHI1B, IncA/C2, IncFIB(Mar), IncX3   *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aadA5*, *aph(3ʹ)-Ic*, *bla*~CTX-M-15~, *bla*~NDM-7~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA17*, *erm*(42), *floR*, *fosA*, *mph*(A), *oqxA*, *oqxB*, *qnrS1*, *sul1*   [NBOL00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOL00000000)
  ARPG-379   68.04                 5,631,243            67               5,613, 19, 77                             273            IncHI1B, IncA/C2, IncFIB(Mar), IncX3   *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aadA5*, *aph(3ʹ)-Ic*, *bla*~CTX-M-15~, *bla*~NDM-7~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA17*, *erm*(42), *floR*, *fosA*, *mph*(A), *oqxA*, *oqxB*, *qnrS1*, *sul1*   [NBOM00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOM00000000)
  ARPG-380   58.73                 5,623,615            75               5,610, 19, 77                             273            IncHI1B, IncA/C2, IncFIB(Mar), IncX3   *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aadA5*, *bla*~CTX-M-15~, *bla*~NDM-7~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA17*, *erm*(42), *floR*, *fosA*, *mph*(A), *oqxA*, *oqxB*, *qnrS1*, *sul1*                 [NBON00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBON00000000)
  ARPG-381   96.98                 5,664,647            73               5,668, 17, 76                             273            IncHI1B, IncA/C2, IncFIB(Mar), IncX3   *aac(3)-IId*, *aac(6ʹ)Ib-cr*, *aadA5*, *aph(3ʹ)-Ic*, *bla*~CTX-M-15~, *bla*~NDM-7~, *bla*~OXA-1~, *bla*~SHV-11~, *bla*~TEM-1B~, *catB3*, *dfrA17*, *erm*(42), *floR*, *fosA*, *mph*(A), *oqxA*, *oqxB*, *qnrS1*, *sul1*   [NBOO00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOO00000000)
  ARPG-489   59.31                 5,521,319            122              5,515, 18, 76                             392            IncFIB(K), IncN, IncFII(K)             *aac(6ʹ)Ib-cr*, *bla*~CTX-M-15~, *bla*~OXA-1~, *bla*~SHV-12~, *bla*~TEM-1B~, *catB3*, *fosA*, *oqxA*, *oqxB*, *qnrB66*, *strA*, *strB*, *sul2*, *tet*(A)                                                                  [NBOP00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOP00000000)
  ARP-657    114.78                5,460,619            74               5,373, 12, 77                             656            IncHI1B, IncFIB(Mar)                   *aac(6ʹ)Ib-cr*, *aadA2*, *armA*, *bla*~CTX-M-15~, *bla*~NDM-1~, *bla*~OXA-1~, *bla*~SHV-1~, *catA1*, *catB3*, *dfrA12*, *fosA*, *mph*(E), *msr*(E), *oqxA*, *oqxB*, *qnrB66*, *sul1*                                      [NBOQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOQ00000000)
  ARP-664    47.78                 5,454,384            79               5,364, 10, 78                             656            IncHI1B, IncFIB(Mar)                   *aac(6ʹ)Ib-cr*, *aadA2*, *armA*, *bla*~CTX-M-15~, *bla*~NDM-1~, *bla*~OXA-1~, *bla*~SHV-1~, *catA1*, *catB3*, *dfrA12*, *fosA*, *mph*(E), *msr*(E), *oqxA*, *oqxB*, *qnrB66*, *sul1*                                      [NBOR00000000](https://www.ncbi.nlm.nih.gov/nuccore/NBOR00000000)

Accession number(s). {#s1}
--------------------

The whole-genome sequences have been deposited at DDBJ/ENA/GenBank under the accession numbers listed in [Table 1](#tab1){ref-type="table"}. The versions described in this paper are the first versions.
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